Biotechnology M&A » By The Online Investor Staff, updated Tue., Apr. 20, 3:34 AM
Recent mergers and acquisitions in the Biotechnology M&A category.
| This Slide: #69 of 83 |
Slide #69. Bio-Rad Laboratories, Inc. — AbD Serotec
Acquirer:
Bio-Rad Laboratories, Inc. (NYSE:BIO)
Acquiree:
AbD Serotec
Details:
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced that it has purchased AbD Serotec, a division of MorphoSys AG, for approximately 53 million euros in cash.
Bio-Rad Laboratories is a manufacturer and distributor of its own life science research and clinical diagnostics products. Co.'s business is organized into two reportable segments: Life Science, which develops, manufactures, sells and services reagents, apparatus and instruments used for biological research; and Clinical Diagnostics, which develops, manufactures, sells and services automated test systems, informatics systems, test kits and quality controls for the healthcare market. Co. sells its products and services to a client base comprised of scientific research, healthcare, education and government customers.
BIO SEC Filing Email Alerts Service
Open the BIO Page at The Online Investor »
|
||||||||||||||||||||||||
Open the BIO Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 97th percentile
(ranked higher than approx. 97% of all stocks covered)
Analysts' Target Price: BIO Stock Forecast Based on Zacks ABR data; powered by Xignite |
